Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients

Multiple Sclerosis

Volumn 15, Issue 12, 2009, Pages 1518-1524

  Honarmand, Kimia ^a,b   Feinstein, Anthony ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Anxiety disorders; Hospital Anxiety and Depression Scale (HADS); Major depressive disorder; Multiple sclerosis

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTIPLE SCLEROSIS; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 72749110305     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509347150     Document Type: Article

References (47)

1. Minden SL, Schiffer RB Affective disorders in multiple sclerosis: review and recommendations for clinical research. Arch Neurol 1990 ; 47: 98-104.
2. Patten SB, Beck MD, Williams VA, Barbui C., Metz LM Major depression in multiple sclerosis. A population-based prospective. Neurology 2003 ; 61: 1524-1527.
3. Sadovnick AD, Remick RA, Allen J., et al. Depression and multiple sclerosis. Neurology 1996 ; 46: 628-632.
4. Korostil M., Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007 ; 13: 67-72.
5. Galeazzi GM, Ferrari S., Giaroli G., et al. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 2005 ; 26: 255-262.
6. Gold SM, Schulz H., Monch A., Schulz KH, Heesen C. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 2003 ; 9: 404-410.
7. BrØnnum-Hansen H., Stenager E., Nylev Stenager E., Koch-Henriksen N. Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005 ; 76: 1457-1459.
8. Feinstein A. Neuropsychiatric syndromes associated with multiple sclerosis. J Neurol 2007 ; 254: 73-76.
9. Beck AT, Steer RA, Brown GK Beck Depression Inventory (BDI)-II Manual. San Antonio, Texas: The Psychological Corporation, 1996.
10. Mohr DC, Goodkin DE, Likosky W., Beutler L., Gatto N., Langan MK Identification of Beck Depression Inventory items related to multiple sclerosis. J Behav Med 1997 ; 20: 407-414.
11. Beck AT, Steer RA, Brown GK BDI-Fast Screen for medical patients manual. San Antonio, Texas: The Psychological Corporation, 2000.
12. Benedict RHB, Fishman I., Bakshi R., Weinstock-Guttman B. Validity of Bec Depression Inventory-Fast Screen in multiple sclerosis. Mult Scler 2003 ; 9: 393-396.
13. Randolph JJ, Arnett PA, Higginson CI, Voss WD Neurovegetative symptoms in multiple sclerosis: relationship to depressed mood, fatigue, and physical disability. Arch Clin Neuropsychol 2000 ; 15: 387-398.
14. Zigmond AS, Snaith RP The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983 ; 67: 361-370.
15. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic-criteria for multiple-sclerosis - guidelines for research protocols. Ann Neurol 1983 ; 13: 227-231.
16. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001 ; 50: 121-127.
17. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002 ; 59: 674-678.
18. Feinstein A., Roy P., Lobaugh N., Feinstein K., OConnor P., Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004 ; 62: 586-590.
19. Kurtzke JF Rating neurologic impairment in multiple-sclerosis - an Expanded Disability Status Scale (EDSS). Neurology 1983 ; 33: 1444-1452.
20. First MB, Spitzer RL, Gibbon M., Williams JBW. Structured clinical interview for Axis 1 DSM-IV disorders - patient edition, SCID-I/P, Version 2.0. New York State Psychiatric Institute, 1994.
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorder, 4 th edn. Washington, DC: American Psychiatric Association, 1994.
22. Altman DG Practical Statistics for Medical Research. Chapman & Hall / CRC 1991.
23. el-Rufaie OEF, Absood GH Retesting the validity of the Arabic version of the Hospital Anxiety and Depression (HAD) scale in primary health care. Soc Psychiatry Psychiatr Epidemiol 1995 ; 30: 26-31.
24. Olsson I., Mykletun A., Dahl AA The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 2005 ; 5: 46.
25. Davies KN, Burn WK, McKenzie FR, Brothwell JA Evaluation of the Hospital Anxiety and Depression Scale as a screening instrument in geriatric medical inpatients. Int J Geriatr Psychiatry 1993 ; 8: 165-169.
26. Flint A., Rifat S. Validation of the Hospital Anxiety and Depression Scale as a measure of severity of geriatric depression. Int J Geriatr Psychiatry 1996 ; 11: 991.
27. Ibbotson T., Maguire P., Selby P., Priestman T., Wallace L. Screening for anxiety and depression in cancer patients - the effects of disease and treatment. Eur J Cancer 1994 ; 30: 37-40.
28. Razavi D., Delvaux N., Farvacques C., Robaye E. Screening for adjustment disorders and major depressive-disorders in cancer inpatients. Br J Psychiatry 1990 ; 156: 79-83.
29. Kugaya A., Akechi T., Okuyama T., Okamura H., Uchitomi Y. Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol 1998 ; 28: 333-338. (Pubitemid 128522959)
30. Razavi D., Delvaux N., Bredart A., et al. Screening for psychiatric disorders in a lymphoma out-patient population. Eur J Cancer 1992 ; 28: 1869-1872.
31. Hosaka T., Awazu H., Aoki T., Okuyama T., Yamawaki S. Screening for adjustment disorders and major depression in otolaryngology patients using the Hospital Anxiety and Depression Scale. Int J Psychiatry Clin Pract 1999 ; 3: 43-48.
32. Ramirez AJ, Richards MA, Jarrett SR, Fentiman IS Can mood disorder in women with breast-cancer be identified preoperatively. Br J Cancer 1995 ; 72: 1509-1512.
33. Abiodun OA A validity study of the Hospital Anxiety and Depression Scale in general hospital units and a community sample in Nigeria. Br J Psychiatry 1994 ; 165: 669-672.
34. Johnson G., Burvill PW, Anderson CS, Jamrozik K., Stewartwynne EG, Chakera TMH. Screening instruments for depression and anxiety following stroke - experience in the Perth Community Stroke Study. Acta Psychiatrica Scandinavica 1995 ; 91: 252-257.
35. Janssens Acjw, Buljevac D., van Doorn PA, et al. Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study. Mult Scler 2006 ; 12: 794-801.
36. Gramigna S., Schluep M., Staub F., et al. Fatigue in neurological disease: different patterns in stroke and multiple sclerosis. Rev Neurol (Paris) 2007 ; 163: 341-348.
37. Bamer AM, Amtmann D., Ehde D., Johnson KL Anxiety in multiple sclerosis: prevalence and associated factors in a large community sample. Mult Scler 2008 ; 14: S155.
38. Feinstein A., OConnor P., Gray T., Feinstein K. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 1999 ; 5: 323-326.
39. Kalia LV, OConnor PW Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler 2005 ; 11: 322-327.
40. Berard RMF, Boermeester F., Viljoen G. Depressive disorders in an outpatient oncology setting: prevalence, assessment, and management. Psychooncology 1998 ; 7: 112-120.
41. Hopwood P., Howell A., Maguire P. Screening for psychiatric morbidity in patients with advanced breast-cancer - validation of 2 self-report questionnaires. Br J Cancer 1991 ; 64: 353-356.
42. Lepine JP, Godchau M., Brun P., Teherani M. UtilitÉ des echelles dauto-evaluation de lanxiÉtÉ et de la depression en mÉdecine interne./Utility of self-assessment scales for anxiety and depression in hospital medicine. Acta Psychiatr Belg 1986 ; 86: 608-615.
43. Putzki N., Katsarava Z., Vago S., Diener HC, Limmroth V. Prevalence and severity of multiple-sclerosis-association fatigue in treated and untreated patients. Eur Neurol 2008 ; 59: 136-142.
44. Hadjimichael O., Vollmer T., Oleen-Burkey M. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 2008 ; 6: 100.
45. Lerdal A., Celius EG, Krupp L., Dahl AA A prospective study of patterns of fatigue in multiple sclerosis. Eur J Neurol 2007 ; 14: 1338-1343.
46. Fisk JD, Ritvo PG, Ross L., Haase DA, Marrie TJ, Schlech WF Measuring the functional impact of fatigue - initial validation of the Fatigue Impact Scale. Clin Infect Dis 1994 ; 18: S79 - S83.
47. Poder K., Ghatavi K., Fisk J., et al. Social anxiety in a multiple sclerosis clinic population. Mult Scler 2009 ; 15: 393-398.